Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Saperconazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 2/20 | 0.78 |
| ▸ | CXCR1 known ✓ | P25024 | 1/20 | 0.78 |
| ▸ | TACR1 known ✓ | P25103 | 1/20 | 0.78 |
| ▸ | PDE4D known ✓ | Q08499 | 1/20 | 0.78 |
| ▸ | PTGS2 known ✓ | P35354 | 1/20 | 0.65 |
| ▸ | CHRM2 known ✓ | P08172 | 2/20 | 0.57 |
| ▸ | ADRA2A known ✓ | P08913 | 2/20 | 0.57 |
| ▸ | ADRA2B known ✓ | P18089 | 2/20 | 0.57 |
| ▸ | SLC6A2 known ✓ | P23975 | 2/20 | 0.57 |
| ▸ | HTR2A known ✓ | P28223 | 2/20 | 0.57 |
| ▸ | SLC6A4 known ✓ | P31645 | 2/20 | 0.57 |
| ▸ | SLC6A3 known ✓ | Q01959 | 2/20 | 0.57 |
| ▸ | CHRM4 known ✓ | P08173 | 1/20 | 0.57 |
| ▸ | CHRM5 known ✓ | P08912 | 1/20 | 0.57 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.57 |
| ▸ | ADRA2C known ✓ | P18825 | 1/20 | 0.57 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.57 |
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.57 |
| ▸ | ADRA1D known ✓ | P25100 | 1/20 | 0.57 |
| ▸ | HTR2C known ✓ | P28335 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Itraconzole SCHEMBL65702 | 0.99 | CYP3A4 (0.79) | CYP3A4ABCG2LMNAMAPTABCB11 | |
| Itraconzole SCHEMBL10073778 | 0.99 | CYP3A4 (0.79) | CYP3A4ABCG2LMNAMAPTABCB11 | |
| Itraconzole SCHEMBL1650334 | 0.99 | CYP3A4 (0.79) | CYP3A4ABCG2LMNAMAPTABCB11 | |
| Saperconazole SCHEMBL65701 | 0.99 | CYP3A4 (0.79) | CYP3A4ABCG2LMNAMAPTABCB11 | |
| Itraconzole SCHEMBL2615053 | 0.99 | CYP3A4 (0.79) | CYP3A4ABCG2LMNAMAPTABCB11 | |
| Itraconzole SCHEMBL12887924 | 0.99 | CYP3A4 (0.79) | CYP3A4ABCG2LMNAMAPTABCB11 | |
| Itraconzole SCHEMBL29371736 | 0.99 | CYP3A4 (0.79) | CYP3A4ABCG2LMNAMAPTABCB11 | |
| Itraconzole SCHEMBL4149722 | 0.99 | CYP3A4 (0.79) | CYP3A4ABCG2LMNAMAPTABCB11 | |
| Itraconzole SCHEMBL17739437 | 0.99 | CYP3A4 (0.79) | CYP3A4ABCG2LMNAMAPTABCB11 | |
| Saperconazole SCHEMBL28133394 | 0.99 | CYP3A4 (0.78) | CYP3A4ABCG2LMNAMAPTABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106749221-B | End Saperconazole monohydrate crystal form and preparation method thereof | 扬子江药业集团有限公司 | 2019-06-21 | — | — | CN | claimed |
| CN-106749221-A | Chinese mugwort Saperconazole monohydrate crystal form and preparation method thereof | 扬子江药业集团有限公司 | 2017-05-31 | — | — | CN | claimed |
| CN-106916152-B | The method of redox reaction preparation Chinese mugwort Saperconazole monosulfate | 扬子江药业集团有限公司 | 2019-09-17 | — | — | CN | disclosed |
| CN-106749221-B | End Saperconazole monohydrate crystal form and preparation method thereof | 扬子江药业集团有限公司 | 2019-06-21 | — | — | CN | disclosed |
| CN-106749221-B | End Saperconazole monohydrate crystal form and preparation method thereof | 扬子江药业集团有限公司 | 2019-06-21 | — | — | CN | disclosed |
| CN-106749221-B | End Saperconazole monohydrate crystal form and preparation method thereof | 扬子江药业集团有限公司 | 2019-06-21 | — | — | CN | disclosed |
| CN-106916152-A | The method that redox reaction prepares Chinese mugwort Saperconazole monosulfate | 扬子江药业集团有限公司 | 2017-07-04 | — | — | CN | disclosed |
| CN-106749221-A | Chinese mugwort Saperconazole monohydrate crystal form and preparation method thereof | 扬子江药业集团有限公司 | 2017-05-31 | — | — | CN | disclosed |
| CN-106749221-A | Chinese mugwort Saperconazole monohydrate crystal form and preparation method thereof | 扬子江药业集团有限公司 | 2017-05-31 | — | — | CN | disclosed |
| CN-106749221-A | Chinese mugwort Saperconazole monohydrate crystal form and preparation method thereof | 扬子江药业集团有限公司 | 2017-05-31 | — | — | CN | disclosed |
| CN-104844652-A | Isavuconazole phosphate ester, preparation method therefor and application thereof | NANJING HAILING PHARMACEUTICAL CO LTD OF YANGTZE RIVER PHARMACEUTICAL GROUP | 2015-08-19 | — | — | CN | disclosed |